SINEFIX-2022 Fase Pilota
Indagine clinica pre-commercializzazione Inovedis SINEFIX
Shoulder pain is one of the most commonly reported musculoskeletal complaints, which negatively affects upper limb use, night rest, daily life activities, work, sports performance and autonomy. Rotator cuff disease represents the most common cause of shoulder pain and it is responsible for up to 70% of all shoulder related visits to clinicians. Its incidence furthermore is expected to grow as the population ages. A wide range of conditions are included under the umbrella term of rotator cuff disease, including rotator cuff tendinopathy, subacromial bursal pathology, and partial-thickness or full-thickness rotator cuff tears (RCTs). The latter ones, i.e. rotator cuff tears, form the indications for which the test devices, the SINEFIX implant and instruments, are intended.
Despite the high prevalence of this condition, the pathophysiology and healing potential are not well understood, making the condition challenging to predictably treat in some patient populations. RCTs may occur in young people as a consequence of trauma (e.g. acute shoulder dislocation), however RCTs typically present in middle-aged or elderly people and cannot always be attributed to precipitating events or trauma. Instead, they can be attributed to degenerative processes, and are therefore referred to as degenerative RCTs.
For RCTs, treatment options include both surgical and non-surgical (conservative) procedures.
In this context, the SINEFIX implant and instruments were developed to treat adult patients with rotator cuff lesions of size up to 2 cm through arthroscopic reconstruction.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Tübingen, Germania, 72074
- Orthopädisch Chirurgisches Centrum (OCC)
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patient indicated for surgical repair of the rotator cuff tear according to current guidelines
- Patient aged 18 years or older
- Up to 2 cm tear size of supraspinatus, infraspinatus (medio-lateral)
- Up to 2 cm tear size of supraspinatus, infraspinatus (anterior-posterior)
Exclusion Criteria:
- Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
- History of alcoholism, drug abuse, psychological or other emotional problems likely to interfere with participation in the study follow-up schedule and assessments
- Inflammatory arthropathies
- Subject with a contraindication/non-compliance for MRI examination
- Subject 's unwillingness to undergo surgical rotator cuff repair, participate in post-operative rehabilitation program, and / or adhere to follow up schedule
- Pregnant and breastfeeding woman
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: SINEFIX
Rotator cuff repair with the SINEFIX implant, using the SINEFIX instruments |
Treatment of rotator cuff lesions of size up to 2 cm using the SINEFIX implant and instruments |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Healing integrity
Lasso di tempo: 3 months post operation
|
Healing integrity will be assessed with the MRI by evaluating the visibility of the tendon underneath the implant (yes/no) |
3 months post operation
|
|
Re-tear rate
Lasso di tempo: 3 months post operation
|
Re-tear rate will be assessed with MRI |
3 months post operation
|
|
Dislocation of the implant
Lasso di tempo: 3 months post operation
|
Presence of dislocation of the implant will be assessed with MRI (yes/no) |
3 months post operation
|
|
Bursitis
Lasso di tempo: 3 months post operation
|
Presence of bursitis will be assessed with MRI (yes/no) |
3 months post operation
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Surgery time
Lasso di tempo: Immediately post procedure
|
The total procedure duration will be recorded as the surgery time |
Immediately post procedure
|
|
Usability and workflow assessment
Lasso di tempo: Immediately post procedure
|
Usability and workflow assessment will be evaluated after each intervention through a practitioner's questionnaire covering different aspects of the implant and instruments |
Immediately post procedure
|
|
Functional and clinical outcome after rotator cuff repair
Lasso di tempo: At 6 months, 1 and 2 years follow-up
|
Functional and clinical outcome after rotator cuff repair will be assessed using the total Constant Murley score, which ranges from 0 (worst outcome) to 100 (best outcome) |
At 6 months, 1 and 2 years follow-up
|
|
Functional and clinical outcome after rotator cuff repair as compared with baseline
Lasso di tempo: At 6 months, 1 and 2 years follow-up
|
Functional and clinical outcome after rotator cuff repair will be assessed using the change of the total Constant Murley score (range 0-100) as compared to baseline |
At 6 months, 1 and 2 years follow-up
|
|
Shoulder function after rotator cuff repair (subjective evaluation)
Lasso di tempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (subjective evaluation) will be assessed through the Subjective Shoulder Value (SSV) which ranges from 0% to 100% (best outcome) |
At 10 weeks, 6, 12, and 24 months
|
|
Shoulder function after rotator cuff repair (physical examination-active external rotation)
Lasso di tempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (physical examination) will be assessed through a physical examination with assessment of range of motion for active external rotation (range 0°-90°) |
At 10 weeks, 6, 12, and 24 months
|
|
Shoulder function after rotator cuff repair (physical examination-active anteversion)
Lasso di tempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (physical examination) will be assessed through a physical examination with assessment of range of motion for active anteversion (0°-180°) |
At 10 weeks, 6, 12, and 24 months
|
|
Healing integrity
Lasso di tempo: At 6, 12, and 24 months
|
Healing integrity will be assessed with the MRI by evaluating the visibility of the tendon underneath the implant (yes/no) |
At 6, 12, and 24 months
|
|
Re-tear rate
Lasso di tempo: At 6, 12, and 24 months
|
Re-tear rate will be assessed with MRI |
At 6, 12, and 24 months
|
|
Dislocation of the implant
Lasso di tempo: At 6, 12, and 24 months
|
Presence of dislocation will be assessed with MRI (yes/no) |
At 6, 12, and 24 months
|
|
Bursitis
Lasso di tempo: At 6, 12, and 24 months
|
Presence of bursitis will be assessed with MRI (yes/no) |
At 6, 12, and 24 months
|
|
Complications
Lasso di tempo: During the follow up time (up to 24 months)
|
Complications will be systematically reported. Complications of particular interest for the purpose of the study are neurological problems, bleeding, impaired wound healing, infection and frozen shoulder. |
During the follow up time (up to 24 months)
|
|
Patient satisfaction
Lasso di tempo: At 10 weeks, 6, 12, 24 months
|
The patient will be asked to rate his/her satisfaction with outcome of the surgical repair (0=completely unsatisfied, 1=unsatisfied, 2=satisfied, 3=completely satisfied) |
At 10 weeks, 6, 12, 24 months
|
|
Safety endpoint
Lasso di tempo: During the intervention and the follow up time (up to 24 months)
|
Safety of the device will be evaluated by systematically reporting device deficiencies (DDs), adverse events (AEs) and serious adverse events (SAEs) and by monitoring the frequency and incidence of these events |
During the intervention and the follow up time (up to 24 months)
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- SINEFIX-2022
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .